Journal of Parkinson’s Disease

Impact Factor
2021
5.568

Volume

11, 4 issues

Latest issue

11:4 online 13 October 2021

Next issue

12:1 scheduled for January 2022

Back volumes

From volume 1, 2011

ISSN print

1877-7171

ISSN online

1877-718X

Aims & Scope

The Journal of Parkinson’s Disease is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal is international and multidisciplinary and aims to promote progress in the epidemiology, etiology, genetics, molecular correlates, pathogenesis, pharmacology, psychology, diagnosis and treatment of Parkinson’s disease. It will publish research reports, reviews, short communications, and letters-to-the-editor and offers very rapid publication and an affordable open access option.

Editorial Board

Editors-in-Chief

Patrik Brundin, MD, PhD
Van Andel Institute
Grand Rapids, MI
USA
Email: patrik.brundin@iospress.com

Bastiaan (Bas) R. Bloem, MD, PhD
Parkinson Centre Nijmegen
Radboud University Nijmegen Medical Centre, Nijmegen
The Netherlands
Email: bas.bloem@iospress.com

Editor-in-Chief Emeritus

J. William Langston, MD
Stanford Udall Center
Department of Pathology, Stanford University, Palo Alto, CA
USA
Email: bill.langston@iospress.com

Associate Editors for Reviews

Daniela Berg
Christian-Albrechts-Universität zu Kiel, Kiel
Germany

Darren Moore
Van Andel Institute, Grand Rapids
USA

Associate Editors

Roy N. Alcalay
Columbia University, New York
USA

Roger Barker
University of Cambridge, Cambridge
United Kingdom

Erwan Bezard
University of Bordeaux, Bordeaux
France

Roongroj Bhidayasiri
Chulalongkorn University, Bangkok
Thailand

Mark R. Cookson
NIH, Bethesda
USA 

Howard Federoff
Georgetown University, Washington
USA

Kelly D. Foote
University of Florida/Fixel Institute for Neurological Diseases, Gainesville
USA

Ziv Gan-Or
Montreal Neurological Institute, McGill University, Montreal
Canada

Thomas Gasser
University of Tuebingen, Tuebingen
Germany

Glenda Halliday
The University of Sydney, Sydney
Australia

Nobutaka Hattori
Juntendo University School of Medicine, Tokyo
Japan

Jeffrey H. Kordower
Rush University, Chicago
USA

Tilo Kunath
University of Edinburgh, Edinburgh
United Kingdom

Peter A. LeWitt
Wayne State University, Detroit, USA
Henry Ford Hospital, Detroit, USA

Tim Lynch
Dublin Neurological Institute at the Mater Hospital, University College Dublin, Dublin
Ireland

Caroline Moreau
Expert Center for Parkinson's Disease, University Hospital of Lille, Lille
France

Alice Nieuwboer
Catholic University Leuven, Leuven
Belgium

Tamas Revesz
University College London, London
United Kingdom

Rodolfo Savica
Department of Neurology, Mayo Clinic, Rochester
USA

Rick Schuurman
Amsterdam University Medical Centers, Amsterdam
The Netherlands

Eng King Tan
Duke NUS Graduate Medical School, Singapore
Singapore

Aleksandar Videnovic
Massachusetts General Hospital, Harvard Medical School, Boston
USA

Laura Volpicelli-Daley
The University of Alabama at Birmingham, Birmingham
USA

Editors of Clinical Trials Highlights

Kevin McFarthing
Parkinson’s Advocate, Innovation Fixer Ltd, Oxford
UK

Tanya Simuni
Parkinson's Disease and Movement Disorders Center, Northwestern University Feinberg School of Medicine, Chicago
USA

Social Media Editor

Kayla Habermehl
Case Western Reserve University, Cleveland
USA

Managing Editor

Bethany Kumar
Case Western Reserve University, Cleveland
USA
Email: jpd@iospress.com

Editorial Board

Dag Aarsland
University of Stavanger, Stavanger
Norway

Asa Abeliovich
Columbia University College of Physicians & Surgeons, New York
USA

Patrick Aebischer
École Polytechnique Fédérale de Lausanne, Lausanne
Switzerland

Yves Agid
Institut du Cerveau et de la Moelle épinière, Paris
France

Alberto Albanese
National Neurological Hospital Carlo Besta, Milan
Italy

Ernest Arenas
Karolinska Institute, Stockholm
Sweden

Alberto Ascherio
Harvard School of Public Health, Boston
USA

M. Flint Beal
Weill Medical College of Cornell University, New York
USA

Alim Benabid
University of Grenoble, Grenoble
France

Hagai Bergman
The Hebrew University, Jerusalem
Israel

Erwan Bezard
University of Bordeaux, Bordeaux
France

Anders Björklund
Lund University, Lund
Sweden

Vincenzo Bonifati
Erasmus MC, Rotterdam
The Netherlands

Heiko Braak
University of Ulm, Ulm, Germany

Jose Bras
University College London, London
United Kingdom

Alexis Brice 
Pierre and Marie Curie University
Paris
France

Helen Bronte-Stewart
Stanford University, Palo Alto
USA

David J. Brooks
Hammersmith Hospital, London,
United Kingdom

Paolo Calabresi
University of Perugia, Perugia
Italy

M. Angela Cenci Nilsson
Lund University, Lund
Sweden

Piu Chan
Beijing Institute of Geriatrics, Beijing
China

K. Ray Chaudhuri
Kings College Hospital, London
United Kingdom

Marie Francoise Chesselet
University of California Los Angeles, Los Angeles
USA

Cynthia Comella
Rush University Medical Center, Chicago
USA

Ted M. Dawson
Johns Hopkins University School of Medicine, Baltimore
USA 

Valina L. Dawson
Johns Hopkins University School of Medicine, Baltimore
USA

Benjamin Dehay
University of Bordeaux, Bordeaux
France

Steve DeWitte
Connecticut Advocates for Parkinson's, New Preston Marble Dale
USA

Dennis Dickson
Mayo Clinic, Scottsdale, USA

Robert H. Edwards
University of California San Francisco, San Francisco
USA 

David Eidelberg
The Feinstein Institute for Medical Research, New York
USA

Omar M. El-Agnaf
United Arab Emirates University, Al-Ain
United Arab Emirates

Alberto Espay
University of Cincinatti, Cincinatti
USA

Stanley Fahn
Columbia University College of Physicians & Surgeons, New York
USA

Matt Farrer
University of British Columbia, Vancouver
Canada

Joaquim Ferreira
Hospital de Santa Maria, Lisbon
Portugal

Tom Foltynie
University College London, London
United Kingdom

Nir Giladi
Tel Aviv University, Tel Aviv
Israel

Ann M. Graybiel
MIT, Cambridge
USA

J. Timothy Greenamyre
University of Pittsburgh, Pittsburgh
USA

James G. Greene
Emory University, Atlanta
USA

Rita Guerreiro
University College London, London
United Kingdom

Katrina Gwinn
NIH, Bethesda
USA

Mark Hallett
NIH, Bethesda
USA

John Hardy
University College London, London
United Kingdom

Etienne C. Hirsch
Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, Paris
France

Joseph Jankovic
Baylor College of Medicine, Houston
USA 

Christine Klein
University of Lübeck, Lübeck
Germany

Han Seok Ko
Johns Hopkins, Baltimore
USA

Amos D. Korczyn
Tel Aviv University, Ramat Aviv
Israel

Dimitri Krainc
Northwestern University, Chicago
USA

Emma L. Lane
Cardiff University, Cardiff
United Kingdom

Matt Lavoie
Harvard Medical School, Boston
USA

Seung-Jae Lee
Konkuk University, Seoul
South Korea

Virginia Lee
University of Pennsylvania School of Medicine, Philadelphia
USA

Olle Lindvall
Lund University, Lund
Sweden

Andres Lozano
University of Toronto, Toronto
Canada 

Laura Marsh
Baylor College of Medicine, Houston
USA

Ian Martin
Oregon Health & Science University, Portland
USA

Soania Mathur
Designing a Cure Inc., Toronto
Canada

Mark P. Mattson
National Institute on Aging, Baltimore
USA

Wassilios Meissner
University Hospital Bordeaux, Bordeaux
France

Eldad Melamed
Tel Aviv University, Tel Aviv
Israel

Robert Nussbaum
University of California San Francisco, San Francisco
USA

Tiago Outeiro
University Medical Center Göttingen, Göttingen
Germany

Jon Palfreman
University of Oregon, Eugene
USA

Ronald F. Pfeiffer
Oregon Health and Sciences University, Portland
USA

Pierre Pollak
University of Grenoble, Grenoble
France

Serge Przedborski
Columbia University Medical Center, New York
USA

Heinz Reichmann
University of Dresden, Dresden
Germany

Peter Riederer
University of Wuerzburg, Wuerzburg
Germany

Olaf Riess
University of Tuebingen, Tuebingen
Germany

Trevor Robbins
University of Cambridge, Cambridge
United Kingdom

Israel Robledo
Parkinson’s Movement, Midland
USA

Marina Romero Ramos
Aarhus University, Aarhus
Denmark

Anthony Schapira
University College London, London
United Kingdom

Sonja Scholz
NIH, Bethesda
USA

Jie Shen
Harvard Medical School, Boston
USA

Todd Sherer
Michael J. Fox Foundation, New York
USA

Ira Shoulson
Georgetown University, Washington
USA

Andrew Singleton
NIH, Bethesda
USA

Richard Smeyne
Thomas Jefferson University, Philadelphia
USA

Yoland Smith
Emory University, Atlanta
USA

Jon Stamford
Parkinson's Movement & The Cure Parkinson's Trust, London
United Kingdom

David G. Standaert
University of Alabama at Birmingham, Birmingham
USA

Leonidas Stefanis
University of Athens Medical School, Athens
Greece

Dennis Steindler
University of Florida, Gainesville
USA

Benjamin Stecher
tmrwedition.com, Toronto
Canada

Fabrizio Stocchi
IRCCS San Raffaele, Rome
Italy

A. Jon Stoessl
University of British Columbia, Vancouver
Canada

David L Sulzer
Columbia University, New York
USA

James Dalton Surmeier
Northwestern University, Chicago
USA

Michele Tagilati
Cedars-Sinai Medical Center, Los Angeles
USA

Jun Takahashi
Kyoto University, Kyoto
Japan

Caroline M. Tanner
The Parkinson's Institute and Clinical Center, Sunnyvale
USA

Malú G Tansey
University of Florida College of Medicine, Gainesville
USA

Bobby Thomas
Medical University of South Carolina, Charleston
USA

Eduardo Tolosa
University of Barcelona, Barcelona
Spain

John Q. Trojanowski
Hospital of the University of Pennsylvania, Philadelphia
USA

Jens Volkmann
Universitätsklinikum Wurzburg, Wurzburg
Germany

Daniel Weintraub
University of Pennsylvania, Philadelphia
USA

Nick Wood
University College London, London
United Kingdom 

Zhenyu Yue
Icahn School of Medicine at Mount Sinai, New York
USA

Founding Editors

From the Journal of Alzheimer’s Disease

George Perry
University of Texas at San Antonio, San Antonio
USA

Mark A. Smith†
Case Western Reserve University, Cleveland, NIH, Bethesda
USA

Author Guidelines

SUBMISSION OF MANUSCRIPT

By submitting my article to this journal, I agree to the Author Copyright Agreement, the IOS Press Ethics Policy, and the IOS Press Privacy Policy.

Please click here to pay your publication fee and/or open access fee. Note: Corresponding authors from eligible institutions may be eligible to a waiver or discount on the open access fee; see here for more details.

See the full instructions to authors on the JPD website.

Abstracted/Indexed in

Biomedical Reference Collection
Chemical Abstracts Service (CAS)
Embase
MEDLINE
OA@PubMedCentral
PsycINFO
PubMed
PubsHub
SciVerse Scopus
Web of Science: Journal Citation Reports/Science Edition
Web of Science: Science Citation Index Expanded (SciSearch®)

Social Media & Sign Ups: The Journal of Parkinson's Disease (JPD) is on Facebook and Twitter, with social media editor Kayla Habermehl at the helm. Be sure to follow us and be part of the conversation! You can sign up to the JPD newsletter to receive alerts of new issues and other journal news via this link tiny.cc/JPDsignup & read the latest newsletter here.

Partnership with WPC: Since April 2020, JPD has partnered with the World Parkinson Coalition (WPC), an organization which fills a unique niche in the global Parkinson's community. The partnership will see our respective teams working together to give a platform to the latest developments in PD research. View the WPC website here.

Clinical Trials Highlights: At the start of 2019, a new journal section co-edited by Kevin McFarthing and Tanya Simuni was launched to raise awareness of the clinical trial landscape in Parkinson’s, promoting discussion and progress in the conduct and outcome of studies; view here.

Parkinson's Webinar Series: JPD works in partnership with The Cure Parkinson’s Trust and Van Andell Institute to produce a series of Quarterly Parkinson's Webinars. Discover more here. The topic of our latest webinar was Genetic Markers in the Progression of Parkinson's. Watch the webinar recording here.

JPD Open Access Special Issues: Repairing the Parkinsonian Brain – Vol.11, Iss.s2; Digital Technology in PD Care & Research – Vol.11, Iss.s1; Clinical Care of Parkinson's – Vol.10, Iss.s1; Gut-Brain Axis in PD – Vol.9, Iss.s2 poses the question as to whether PD stars in the gut for all patients or a small subgroup; and PD 20 Years from Now – Vol.8, Iss.s1 addresses where Parkinson's research & treatment will be 20 years from now and you can read more in the mailing here.

JPD special issue banner

JPD OA special issue banner

JPD sign-up-for-news-banner

JPD OA special issue banner

 

CPT ad on the JPD page

 

JPD webinar banner

 

EPDA ad on JPD page

 

WPC banner on JPD page

JPD COVID-19 content banner

   
PD webinar 13 banner